AU2005215790A1 - Treatment or prophylaxis of migraine or headache disorders using citalopram, escitalopram or citalopram metabolites - Google Patents
Treatment or prophylaxis of migraine or headache disorders using citalopram, escitalopram or citalopram metabolites Download PDFInfo
- Publication number
- AU2005215790A1 AU2005215790A1 AU2005215790A AU2005215790A AU2005215790A1 AU 2005215790 A1 AU2005215790 A1 AU 2005215790A1 AU 2005215790 A AU2005215790 A AU 2005215790A AU 2005215790 A AU2005215790 A AU 2005215790A AU 2005215790 A1 AU2005215790 A1 AU 2005215790A1
- Authority
- AU
- Australia
- Prior art keywords
- citalopram
- headache
- effective amount
- pharmaceutically acceptable
- polymorph
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54571004P | 2004-02-17 | 2004-02-17 | |
| US60/545,710 | 2004-02-17 | ||
| PCT/US2005/005111 WO2005079787A1 (en) | 2004-02-17 | 2005-02-17 | Treatment or prophylaxis of migraine or headache disorders using citalopram, escitalopram or citalopram metabolites |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2005215790A1 true AU2005215790A1 (en) | 2005-09-01 |
Family
ID=34886186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2005215790A Abandoned AU2005215790A1 (en) | 2004-02-17 | 2005-02-17 | Treatment or prophylaxis of migraine or headache disorders using citalopram, escitalopram or citalopram metabolites |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7714023B2 (https=) |
| EP (1) | EP1720541A1 (https=) |
| JP (1) | JP2007523176A (https=) |
| AU (1) | AU2005215790A1 (https=) |
| CA (1) | CA2556424A1 (https=) |
| WO (1) | WO2005079787A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10086026B2 (en) * | 2016-06-27 | 2018-10-02 | Uwais M. Syed | Combined herbal and pharmaceutical composition and method |
| KR102331187B1 (ko) * | 2019-04-09 | 2021-11-26 | 주식회사 라이트팜텍 | 에스시탈로프람을 함유하는 안정성이 우수한 경구용 액제 조성물 및 그의 제조방법 |
| WO2023101866A1 (en) * | 2021-12-01 | 2023-06-08 | Zogenix International Limited | Fenfluramine for treatment of conditions associated with spreading depolarization |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002076461A1 (en) | 2001-03-26 | 2002-10-03 | Serdar Murat Dursun | Combination of reboxetine and citalopram |
| US20050014848A1 (en) * | 2002-01-23 | 2005-01-20 | Pfizer Inc. | Combination of serotonin reuptake inhibitors and norephinephrine reuptake inhibitors |
| WO2003072138A1 (en) | 2002-02-26 | 2003-09-04 | Ortho-Mcneil Pharmaceutical Inc. | Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents |
| GB2392385A (en) | 2002-09-02 | 2004-03-03 | Cipla Ltd | Pharmaceutical preparations comprising a 5HT uptake inhibitor and a homopolymer or copolymer of N-vinyl pyrrolidone |
-
2005
- 2005-02-17 WO PCT/US2005/005111 patent/WO2005079787A1/en not_active Ceased
- 2005-02-17 US US11/060,067 patent/US7714023B2/en active Active
- 2005-02-17 EP EP05723234A patent/EP1720541A1/en not_active Withdrawn
- 2005-02-17 CA CA002556424A patent/CA2556424A1/en not_active Abandoned
- 2005-02-17 JP JP2006554214A patent/JP2007523176A/ja not_active Withdrawn
- 2005-02-17 AU AU2005215790A patent/AU2005215790A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US7714023B2 (en) | 2010-05-11 |
| JP2007523176A (ja) | 2007-08-16 |
| US20050192344A1 (en) | 2005-09-01 |
| EP1720541A1 (en) | 2006-11-15 |
| WO2005079787A1 (en) | 2005-09-01 |
| CA2556424A1 (en) | 2005-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101784273B (zh) | (2s，3r)‑n‑(2‑((3‑吡啶基)甲基)‑1‑氮杂双环[2.2.2]辛‑3‑基)苯并呋喃‑2‑甲酰胺、其新的盐形式和用法 | |
| JP2019031502A (ja) | モノアミン神経伝達物質によって影響を受ける病態の処置における（＋）−１−（３，４−ジクロロフェニル）−３−アザビシクロ［３．１．０］ヘキサンの調製および使用 | |
| TW200810752A (en) | Modulators of muscarinic receptors | |
| PT885220E (pt) | Derivados de tropano a sua preparacao e utilizacao | |
| TW458777B (en) | Pharmaceutical compositions for treating affective disorders | |
| JPH09504287A (ja) | 新規な（ｒ）−５−カルバモイル−８−フルオロ−３−ｎ，ｎ−ジ置換−アミノ−３，４−ジヒドロ−２ｈ−１−ベンゾピラン | |
| AU688748B2 (en) | Enantiomers of carbazole derivatives as 5-HT1-like agonists | |
| JP2021513972A (ja) | 社会的機能障害の治療方法 | |
| JPWO1999007667A1 (ja) | 新規なエチルアミン誘導体 | |
| EP1096926B1 (en) | Methods and compounds for treating depression | |
| KR20240158951A (ko) | 결정질 아티카프란트의 순수한 형태 | |
| RU2042680C1 (ru) | 1-[пиридо(3,4-b) -1,4-оксазинил -4-ил] -1н-индолы, способ их получения, композиция на их основе и производное n-(4-пиридинил)-1н-индол-1-амина | |
| US20040266864A1 (en) | Methods for treating depression and other CNS disorders using enantiomerically enriched desmethyl-and didesmethyl-metabolites of citalopram | |
| US7714023B2 (en) | Treatment or prophylaxis of migraine or headache disorders using citalopram, escitalopram or citalopram metabolites | |
| US20110059983A1 (en) | Use of substituted oxindole derivatives for the treatment and prophylaxis of pain | |
| TW201630902A (zh) | 化合物、組合物及方法 | |
| AU2002348266A1 (en) | Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof | |
| JP2015187122A (ja) | ピロリジントリプル再取込み阻害剤 | |
| WO2005002578A1 (en) | Compositions containing a serotonin selective reuptake inhibitor and a 5-ht2a receptor antagonist | |
| US4141993A (en) | Compounds of diphenylcyclopentylamine type and methods for their preparation | |
| JP2009536644A (ja) | 中枢神経系活動に用いるシクロプロパン | |
| CA2756876A1 (en) | A process for the preparation of frovatriptan and frovatriptan succinate and their synthetic intermediates | |
| TW200534848A (en) | 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of movement disorders | |
| WO2012129262A1 (en) | Treatment of attention deficit/hyperactivity disease | |
| EA010666B1 (ru) | Производные 2-(1h-индолилсульфанил)бензиламина в качестве ssri |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |